Bruker Corporation filings document financial results, capital returns, governance actions and proxy matters for a scientific instruments and diagnostics company.
Recent Form 8-K disclosures cover quarterly and annual operating results, outlook commentary, segment information for Bruker Scientific Instruments and Bruker Energy & Supercon Technologies, and dividends on common stock and 6.375% Mandatory Convertible Preferred Stock, Series A. The definitive proxy statement covers board elections, executive compensation, pay-versus-performance data, shareholder voting items and governance practices. Other material-event filings record board composition changes and executive transition arrangements.
Bruker Corporation insider grant to its President & CEO. The filing reports that on 08/15/2025 Burkhard Prause, listed as President & CEO, was granted 5,298 Restricted Stock Units (RSUs) and 5,008 stock options with an exercise price of $33.52. The RSUs vest in four equal annual installments beginning on the first anniversary of the 08/15/2025 grant date, and the options vest on the same four-year annual schedule with an exercisable date beginning 08/15/2026 and expiration on 08/15/2035. After the RSU grant the reporting person beneficially owned 25,158 shares. The form is signed by an attorney-in-fact on 08/19/2025.
Frank H. Laukien, President & CEO, Director and 10% owner of Bruker Corporation (BRKR), had restricted stock units vest and had 12,917 shares withheld across three dates to satisfy tax withholding: 3,422 shares on 08/09/2025 at $30.43, 4,657 shares on 08/10/2025 at $30.43, and 4,838 shares on 08/11/2025 at $30.78. The transactions are coded F, indicating company withholding rather than open-market sales.
Following the withholdings, his reported direct beneficial ownership was about 38.45 million shares (38,445,672 after the 08/11 transaction). The filing also lists indirect holdings including 1,055,639 shares by a former spouse and various family/UTMA holdings, showing structured family ownership but no additional dispositions reported.
Mark Munch, Executive Vice President and President of Bruker Nano Inc., reported three non-derivative transactions in Bruker Corporation (BRKR) common stock related to restricted stock unit vesting. The Form 4 shows shares were withheld to satisfy tax withholding obligations: 1,340 shares on 08/09/2025 at $30.43, 1,107 shares on 08/10/2025 at $30.43, and 1,279 shares on 08/11/2025 at $30.78. Each transaction is reported as a direct ownership change and coded as F with the company’s explanation confirming tax withholding for RSU vesting.
Following these withholdings, the reported direct beneficial ownership amounts after each transaction were 107,198, 106,091 and 104,812 shares respectively, reflecting a total of 3,726 shares withheld across the three dates.
Herman Gerald N., Executive Vice President and CFO of Bruker Corporation, reported the withholding of vested restricted stock units to satisfy tax obligations. The Form 4 shows three withholding transactions over August 9–11, 2025: 1,846 shares on 08/09 at $30.43, 1,380 shares on 08/10 at $30.43, and 1,420 shares on 08/11 at $30.78. The company’s explanatory note states these shares were withheld to cover taxes arising from vesting of previously granted RSUs.
Following the reported transactions, the filing lists beneficial ownership declining across those dates to 79,539, then 78,159, and finally 76,739 shares held directly by the reporting person. These entries are recorded under Transaction Code F and are presented as direct ownership on the Form 4.